Irinotecan Hydrochloride Injection
Product Images NDC 0143-9583
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloride (NDC 0143-9583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Survival Second-line Irinotecan Vs Best Supportive Care (bsc) Study 7 (Irinotecan Hydrochloride Injection Usp Novation 2)
Figure 2. Survival Second-line Irinotecan Vs Infusion 5-fu Study 8 (Irinotecan Hydrochloride Injection Usp Novation 3)
Ndc 0143-9583-01 Rx Only Irinotecan Hydrochloride Injection, Usp 100 mg/5 mL (20 mg/ml) As The Trihydrate For Iv Use Only Must Be Diluted (CYTOTOXIC AGENT 5 mL Single Dose Vial USUAL DOSAGE: See package insert. PROTECT FROM LIGHT. PROTECT FROM FREEZING. Store at 20º to 25ºC (68º to 77ºF); excursions permitted to 15º to 30ºC (59º to 86ºF) [See USP].)
Ndc 0143-9583-01 Rx Only Irinotecan Hydrochloride Injection, Usp 100 mg/5 mL (20 mg/ml)* As The Trihydrate For Intravenous Use Only Must Be Diluted Cytotoxic Agent 1 X 5 mL Single Dose Vial (Irinotecan Hydrochloride Injection Usp Novation 5)
Irinotecan Hydrochloride Injection Usp Novation 6
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.